The lecture, titled “The Molecular Origin of Pulmonary Arterial Hypertension,” will be held Nov. 8, 2012, at 4 p.m. in the Medical Sciences Building auditorium on USA’s main campus.
Dr. Bonnet’s research primarily focuses on pulmonary arterial hypertension (PAH), chronic obstructive pulmonary disease (COPD), and coronary disease.
The accomplishments of Dr. Bonnet led to the discovery of mechanisms that cause pulmonary arterial hypertension, a fatal disease that mainly strikes young adults. His team also discovered two substances likely to treat this disease effectively.
Dr. Bonnet earned a doctorate in vascular physiopathology in France and a post doctorate in vascular biology in Alberta.
He has received numerous awards, including the 2011 Fellow of the American Heart Association, Best Canadian Research in Hypertension (CHC), the Paul Mann Award in Translational Research (University of Alberta), the Muster Fraser Award (CIHR award), and the Cournand and Comroe Award (AHA).
In addition, he has authored papers regarding pulmonary hypertension research for several journals, including Circulation, Journal of Experimental Medicine, Cellular and Molecular Life Sciences, Journal of Steroids and Hormonal Science, and Journal of Molecular Medicine.
For more information on Dr. Bonnet’s research, click here.
